Stemline Therapeutics Competitors and Similar CompaniesClear all

Stemline Therapeutics's competitors and similar companies include Statera Biopharma, Signpath Pharma, Carrick Therapeutics and Taiho Oncology.

	Stemline Therapeutics Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells.	Statera Biopharma Statera Biopharma (formerly known as Cytocom) is a pre-clinical and clinical biopharmaceutical company that develops product candidates for treating diseases involving immune system dysfunction.	Signpath Pharma SignPath Pharma is a biotechnology company that develops products to treat cancer and mitigate drug-induced cardiac arrhythmia.	Carrick Therapeutics Carrick Therapeutics is pioneering a portfolio of unique, first in class, cancer treatments.	Taiho Oncology Taiho Oncology is a pharmaceutical company engaged in the discovery and development of cancer treatments.
Founding Date	Founding Date 2003	Founding Date 2003	Founding Date 2006	Founding Date 2015	Founding Date 2002
Type	Type Public	Type Public	Type Private	Type Private	Type Subsidiary
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations New York, US HQ	Locations Fort Collins, US HQ Fort Collins, US	Locations Sandy, US HQ	Locations Dublin, IE HQ Oxford, GB	Locations Singapore, SG HQ Oakville, CA Chiyoda City, JP Birmingham, GB Menlo Park, US Princeton, US
Employees	Employees 100	Employees 16	Employees 11	Employees 17	Employees 4191% increase
Valuation ($)	Valuation ($) 621.2 m	Valuation ($) 21.4 k	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A
Financial
Cost of goods	Cost of goods $4.9m (FY, 2019)	Cost of goods $488.3k (FY, 2021)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Net income	Net income ($76.8m) (FY, 2019)	Net income ($101.9m) (FY, 2021)	Net income N/A	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 12.2m	Total funding raised $ 5.3m	Total funding raised $ 95m	Total funding raised N/A

For sources of this data, please see the company profile

View Company Profiles

Statera Biopharma

Fort Collins, US

Employees

Statera Biopharma (formerly known as Cytocom) is a pre-clinical and clinical biopharmaceutical company that develops product candidates for treating diseases involving immune system dysfunction.

View company

Signpath Pharma

Sandy, US

Employees

SignPath Pharma is a biotechnology company that develops products to treat cancer and mitigate drug-induced cardiac arrhythmia.

View company

Carrick Therapeutics

Dublin, IE

Employees

Carrick Therapeutics is pioneering a portfolio of unique, first in class, cancer treatments.

View company

Taiho Oncology